Real-time enrollment status for this neuropathic pain clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 9:33 AM UTC
| NCT Number | NCT07363395 |
| Recruiting Status | Recruiting |
| Condition | Neuropathic Pain |
| Phase | PHASE1 |
| Target Enrollment | 72 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Alcamena Stem Cell Therapeutics |
| Last Updated on CT.gov | June 16, 2026 (Jun 16, 2026) |
As of July 20, 2026: Clinical trial NCT07363395 is currently recruiting participants. This phase1 study for neuropathic pain is actively seeking new participants at 1 location across the United States. The study is sponsored by Alcamena Stem Cell Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07363395 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07363395 was last updated Jun 16, 2026 (June 16, 2026). HelloStudys verifies this status automatically.